tiprankstipranks
Invivyd (IVVD)
NASDAQ:IVVD
US Market
IVVD
Invivyd
RESEARCH TOOLSreports

Invivyd (IVVD) Stock News & Sentiment

799 Followers
Invivyd: Multi‑Virus Antibody Platform Progress and Pivotal COVID-19 Trial Support Buy Rating and $10 Target
Premium
Ratings
Invivyd: Multi‑Virus Antibody Platform Progress and Pivotal COVID-19 Trial Support Buy Rating and $10 Target
2d ago
IVVD
Invivyd Advances COVID-19 Program and Launches Measles Antibody
Premium
Company Announcements
Invivyd Advances COVID-19 Program and Launches Measles Antibody
3d ago
8K
IVVD
Invivyd Earnings Call Highlights Pivotal Trial Momentum
Premium
Company Announcements
Invivyd Earnings Call Highlights Pivotal Trial Momentum
1M ago
IVVD
Invivyd: Accelerating PEMGARDA Uptake and Strong Cash Runway Position VYD2311 as a De‑Risked Growth Catalyst
Premium
Ratings
Invivyd: Accelerating PEMGARDA Uptake and Strong Cash Runway Position VYD2311 as a De‑Risked Growth Catalyst
1M ago
IVVD
Invivyd: Late‑Stage COVID-19 Antibody Progress and Solid Fundamentals Support Buy Rating
Premium
Ratings
Invivyd: Late‑Stage COVID-19 Antibody Progress and Solid Fundamentals Support Buy Rating
1M ago
IVVD
Invivyd Advances VYD2311 With Key Phase 3 Alignments
Premium
Company Announcements
Invivyd Advances VYD2311 With Key Phase 3 Alignments
1M ago
8K
IVVD
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now?
Premium
Market News
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now?
2M ago
XBI
ERAS
More IVVD News >

IVVD News on the Web

Invivyd: Multi‑Virus Antibody Platform Progress and Pivotal COVID-19 Trial Support Buy Rating and $10 Target
TipRanks News
Bullish
Invivyd (IVVD) Shares Climb on Progress in COVID-19 Therapy Trial
GuruFocus News
Bullish
Invivyd provides update on Phase 3 DECLARATION study of VYD2311
TipRanks News
Bullish
Invivyd announces discovery, advancement of measles antibody candidate VMS063
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA), Medtronic (MDT) and Invivyd (IVVD)
TipRanks News
Bullish
Invivyd Advances VMS063 as a Potential First-in-Class Measles Antibody and Strengthens COVID-19 Pipeline
Market Chameleon
Neutral
Invivyd Advances COVID-19 Program and Launches Measles Antibody
TipRanks News
Bullish
Cantor Fitzgerald Remains a Buy on Invivyd (IVVD)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
IVVD
Sector Average
Media Buzz
This Week7 articles
Weekly Average2 articles
News Sentiment
This Week99%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IVVD’s Media Buzz Sentiment?
7 articles about IVVD were published this week. In an average week, 2 articles are published.
    What is IVVD’s weekly average amount of articles?
    In an average week, 2 articles about IVVD are published.
      What is IVVD’s News Sentiment?
      99% of articles about IVVD were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week